Sean Godbout
Fortune : 263 032 $ au 31/05/2026
Fortune : 263 032 $ au 31/05/2026
Sean Godbout is currently the Chief Executive Officer at Conforma Therapeutics Corp.
Mr. Godbout is also the Chief Accounting Officer, VP & Global Controller at Biogen, Inc., a position starting in 2025.
Mr. Godbout completed undergraduate studies at Cornell University.
Mr. Godbout completed graduate studies and earned an MBA at Northeastern University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOGEN INC. 0 % | 01/04/2026 | 1 342 ( 0 % ) | 263 032 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIOGEN INC. | Comptroller/Controller/Auditor | 01/01/2007 |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national